Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

Published:2007-07 Issue:9581 Volume:370 Page:29-38
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Madruga José Valdez,Cahn Pedro,Grinsztejn Beatriz,Haubrich Richard,Lalezari Jacob,Mills Anthony,Pialoux Gilles,Wilkin Timothy,Peeters Monika,Vingerhoets Johan,de Smedt Goedele,Leopold Lorant,Trefiglio Roberta,Woodfall Brian

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2006

2. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy;Bacheler;J Virol,2001

3. Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen;Delaugerre;J Med Virol,2001

4. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob Agents Chemother,2004

5. TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments;Vingerhoets;J Virol,2005

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. Delayed identification of treatment failure causes high levels of acquired drug resistance and less future drug options among HIV-1-infected South Indians;Indian Journal of Medical Microbiology;2024-01

3. Dermatological manifestations of HIV: Implications for esthetic and clinical management;Aesthetics International;2024-01

4. A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine;International Journal of Translational Medicine;2023-10-27

5. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22